Regeneron Pharmaceuticals (REGN) traded to the upside until mid-morning Tuesday and rose further going into the close. The stock closed higher by $1.49 at $28.00.
Regeneron Pharmaceuticals has been gaining ground for the past 2 weeks and finished Tuesday at a new high for the year.
For comments and feedback: editorial@rttnews.com